NUPLAZID: New Drug Trials Snapshot Posted

A new DRUG TRIALS SNAPSHOT FOR NUPLAZID is now available.

NUPLAZID is a drug for the treatment of hallucinations and delusions in patients with Parkinson’s disease. People who experience hallucinations and delusions see or hear things that are not there and/or have false beliefs.

Drug Trials Snapshots provide information about who participated in clinical trials that supported the FDA approval of new drugs. The information provided in these Snapshots also highlights whether there were any differences in the benefits and side effects among sex, race and age groups.

See more Drug Trial Snapshots or contact us with questions at Snapshots@fda.hhs.gov.